Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. VTRS
VTRS logo

VTRS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VTRS News

Viatris Receives Overweight Rating and Price Target

3d agoYahoo Finance

Mark Cuban to Join Trump for Generic Drug Announcement

May 18 2026seekingalpha

Viatris' NDA for Fast-Acting Meloxicam Accepted by FDA

May 18 2026Newsfilter

HHS Considers Restrictions on Antidepressant Use Amid Mental Health Crisis

May 08 2026seekingalpha

Viatris to Present at Bank of America Healthcare Conference

May 07 2026PRnewswire

Viatris Reports Strong Q1 2026 Earnings with $3.5 Billion Revenue

May 07 2026seekingalpha

Viatris Reaffirms Full-Year Outlook, Shares Surge

May 07 2026seekingalpha

Viatris Executive Anticipates Mid to High Single-Digit Revenue Growth in Greater China by 2026 - Conference Call

May 07 2026moomoo

Viatris Q1 Earnings Exceed Expectations

May 07 2026seekingalpha

Viatris Set to Report Q1 Earnings Amid Pricing Pressures

May 06 2026seekingalpha

Viatris Declares $0.12 Quarterly Dividend, Maintaining 3.16% Yield

May 05 2026seekingalpha

Edwards Lifesciences Appoints New CFO

May 05 2026NASDAQ.COM

Viatris CFO Theodora Mistras to Depart for New Opportunity

May 05 2026NASDAQ.COM

Edwards Lifesciences Appoints New Executive

May 04 2026Yahoo Finance

Viatris CFO Theodora Mistras to Depart for New Opportunity

May 04 2026seekingalpha

Viatris CFO Departure; Paul Campbell Named Interim CFO

May 04 2026PRnewswire